Cell Therapy and Regenerative Medicine


The Cell Therapy and Regenerative Medicine Program (CellReGen) at the University of Utah provides safe, high-quality products for therapeutic use and research. CellReGen facilitates the availability of cellular and tissue-based therapies to patients by bridging efforts in basic research, bioengineering, and the medical sciences. CellReGen has the expertise and infrastructure to address complex regulatory, financial and manufacturing challenges associated with delivering cell and tissue-based products to patients.

If you have a new project needing Cell Therapy lab resources, please complete a request for collaboration by Clicking Here

HPCT and Cellular Therapy Fellowship Program

Now Accepting Applications for the 2022-2023 Academic Year.More Information


CellReGen provides multi-disciplinary support services ranging from Hematopoietic Stem Cell Transplant to Contract Research, Product Development, and Manufacturing of pharmaceutical, cellular and tissue-based products.

More Information

Product Development

CellReGen manufactures a number of products for distribution, products created in-house after years of research, technical development, and testing. These products are of cellular and non-cellular human origin and can be used for a variety of applications:

More Information

Clinical Research

CellReGen is committed to scientific excellence through academic and industry collaboration.

Clinical Trial Requests